Tags

Type your tag names separated by a space and hit enter

Antiviral agents for treating influenza.
Cleve Clin J Med. 2000 Feb; 67(2):92-5.CC

Abstract

The new neuraminidase inhibitors zanamivir and oseltamivir are important additions to the treatment of influenza, being the first class of agents active against both influenza A and influenza B. The decision to use these agents rather than amantadine or rimantadine, which are effective only against influenza A, should be based on the age of the patient, antiviral activity, side effect profile, ease of administration, drug interactions, and cost. All of these agents are effective only when started within 24 to 48 hours of onset of symptoms. To avoid inappropriate use of these agents, treatment should be continued only in patients with a confirmed diagnosis of influenza. Although effective in decreasing symptoms, none of these agents prevent pneumonia or hospitalization secondary to influenza.

Authors+Show Affiliations

Department of Pharmacy, Cleveland Clinic, USA.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

10680275

Citation

Long, J K., et al. "Antiviral Agents for Treating Influenza." Cleveland Clinic Journal of Medicine, vol. 67, no. 2, 2000, pp. 92-5.
Long JK, Mossad SB, Goldman MP. Antiviral agents for treating influenza. Cleve Clin J Med. 2000;67(2):92-5.
Long, J. K., Mossad, S. B., & Goldman, M. P. (2000). Antiviral agents for treating influenza. Cleveland Clinic Journal of Medicine, 67(2), 92-5.
Long JK, Mossad SB, Goldman MP. Antiviral Agents for Treating Influenza. Cleve Clin J Med. 2000;67(2):92-5. PubMed PMID: 10680275.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Antiviral agents for treating influenza. AU - Long,J K, AU - Mossad,S B, AU - Goldman,M P, PY - 2000/2/19/pubmed PY - 2000/3/18/medline PY - 2000/2/19/entrez SP - 92 EP - 5 JF - Cleveland Clinic journal of medicine JO - Cleve Clin J Med VL - 67 IS - 2 N2 - The new neuraminidase inhibitors zanamivir and oseltamivir are important additions to the treatment of influenza, being the first class of agents active against both influenza A and influenza B. The decision to use these agents rather than amantadine or rimantadine, which are effective only against influenza A, should be based on the age of the patient, antiviral activity, side effect profile, ease of administration, drug interactions, and cost. All of these agents are effective only when started within 24 to 48 hours of onset of symptoms. To avoid inappropriate use of these agents, treatment should be continued only in patients with a confirmed diagnosis of influenza. Although effective in decreasing symptoms, none of these agents prevent pneumonia or hospitalization secondary to influenza. SN - 0891-1150 UR - https://www.unboundmedicine.com/medline/citation/10680275/Antiviral_agents_for_treating_influenza_ L2 - https://medlineplus.gov/flu.html DB - PRIME DP - Unbound Medicine ER -